longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Green Thumb Industries Inc.

GTBIF

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 13.69, below the reasonable range, cheaper than 80.2% of the time in the past 5 years, and the industry ranks 19/258, the industry Median -1.32.

13.69xP/E
$7.49Stock price
$0.55Earnings per share
13.69xP/E
Stock price$7.49Earnings per share$0.55

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
31.68x
Typical range
13.73x–67.85x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
NVOUSNovo Nordisk AS
10.76x7.88%$194.65B
BMYUSBristol Myers Squibb
14.03x62.25%$130.22B
GSKUSGSK
15.21x6.56%$98.05B
UCBJYUSUCB S.A.
17.53x--$44.64B
HLNUSHaleon
18.72x2.92%$40.61B
OTSKYUSOtsuka Pharmaceutical
14.93x--$38.66B
DSNKYUSDaiichi Sankyo
18.96x--$31.84B
ZTSUSZoetis
11.42x6.81%$30.11B
ALPMYUSAstellas Pharma
10.94x--$25.50B
JAZZUSJazz Pharma
16.59x348.40%$15.61B
OPHLYUSOno Pharmaceutical
14.36x--$6.99B
INDVUSIndivior Pharmaceuticals
11.44x126.83%$4.07B
OGNUSOrganon
17.13x211.11%$3.58B
SNPHYUSSanten Pharmaceutical
14.19x--$3.51B
HRMYUSHarmony Biosciences
13.20x45.48%$2.39B
PBHUSPrestige Brands
13.04x7.48%$2.24B
GTBIFUSGreen Thumb Industries Inc.
13.69x--$1.74B
ANIPUSANI Pharma
16.12x49.55%$1.61B
PAHCUSPhibro Animal Health
14.89x26.75%$1.49B
OMERUSOmeros
10.78x1,880.00%$1.35B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.